Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure
Interventional
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Estimate the proportion of women in the 2 age groups who develop recovery of ovarian function within 12 months of Al Monotherapy
12 months
No
Norah L. Henry, M.D., Ph.D.
Principal Investigator
University of Michigan
United States: Food and Drug Administration
UMCC 2007.044
NCT00555477
August 2007
January 2016
Name | Location |
---|---|
University of Michigan | Ann Arbor, Michigan 48109-0624 |
Dana-Farber Cancer Center | Boston, Massachusetts 02115 |
Sidney Kimmel Comprehensive Center at Johns Hopkins | Baltimore, Maryland 21231-2410 |